Eric J. Daniels's most recent trade in Kiora Pharmaceuticals Inc was a trade of 15,543 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 15,543 | 15,543 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 7,772 | 26,375 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 14,710 | 14,710 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 7,355 | 18,577 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 14 Jun 2024 | 1,431 | 11,222 (0%) | 0% | 5.3 | 7,570 | Common Stock |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 15,600 | 25,838 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 10,400 | 10,400 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 10,000 | 10,238 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2021 | 9,520 | 9,520 (0%) | 0% | - | Common Stock |